Zih-Syuan Yang , Albright Dew Baua , Mahmoud Salama Hemdan , Wanchai Assavalapsakul , Wen-Hung Wang , Chun-Yu Lin , Day-Yu Chao , Yen-Hsu Chen , Sheng-Fan Wang
{"title":"Dengue virus infection: A systematic review of pathogenesis, diagnosis and management","authors":"Zih-Syuan Yang , Albright Dew Baua , Mahmoud Salama Hemdan , Wanchai Assavalapsakul , Wen-Hung Wang , Chun-Yu Lin , Day-Yu Chao , Yen-Hsu Chen , Sheng-Fan Wang","doi":"10.1016/j.jiph.2025.102982","DOIUrl":null,"url":null,"abstract":"<div><div>Dengue fever (DF), caused by the dengue virus (DENV), remains a significant global health threat. Despite its impact, no specific antiviral treatments exist, and accurate diagnosis is critical for effective management. This review explores DENV pathogenesis, diagnostic approaches, and management strategies. Host-virus interactions, including antibody-dependent enhancement (ADE), cross-reactive memory T cells, and anti-DENV NS1 antibodies, are key factors in disease progression. Viral proteins, such as the envelope (E) and NS1, along with genome variations, contribute to disease severity. Diagnostic methods have evolved from conventional assays to rapid serological assays and point-of-care tests, enhancing early detection. However, clinical management remains supportive, focusing on fluid resuscitation tailored to the patient's clinical status, close monitoring of vital signs, and judicious use of blood products for severe cases. This study suggests that a deeper understanding of DENV pathogenesis, improved diagnostic tools, and the development of effective therapeutics are essential for optimizing dengue management.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 12","pages":"Article 102982"},"PeriodicalIF":4.0000,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125003314","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Dengue fever (DF), caused by the dengue virus (DENV), remains a significant global health threat. Despite its impact, no specific antiviral treatments exist, and accurate diagnosis is critical for effective management. This review explores DENV pathogenesis, diagnostic approaches, and management strategies. Host-virus interactions, including antibody-dependent enhancement (ADE), cross-reactive memory T cells, and anti-DENV NS1 antibodies, are key factors in disease progression. Viral proteins, such as the envelope (E) and NS1, along with genome variations, contribute to disease severity. Diagnostic methods have evolved from conventional assays to rapid serological assays and point-of-care tests, enhancing early detection. However, clinical management remains supportive, focusing on fluid resuscitation tailored to the patient's clinical status, close monitoring of vital signs, and judicious use of blood products for severe cases. This study suggests that a deeper understanding of DENV pathogenesis, improved diagnostic tools, and the development of effective therapeutics are essential for optimizing dengue management.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.